Johnson & Johnson Surgical Vision
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Johnson & Johnson Surgical Vision sits in the top decile of US sponsors by registered trial count (#696 of 15,742 sponsors by registered trial count).
Johnson & Johnson Surgical Vision: 22 sponsored US clinical trials, 1 recruiting.
Johnson & Johnson Surgical Vision sponsors 22 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 18 completed. The most-studied condition in this pipeline is Corneal Astigmatism, with 2 trials.
Top-decile sponsor footprint
Johnson & Johnson Surgical Vision ranks in the top decile of sponsors by registered trial count (#696 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
18 of 21 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
22 total, page 1 of 1
Objective Assessment of Intraocular Lens Tilt and Decentration
NCT07324200
Comparison of Methods for Assessing Intraocular Lens Position
NCT07218419
Measurement of Refractive Error in Pseudophakic Eyes Using an Autorefractor and a Wavefront Aberrometer
NCT06797856
Prospective, Multi-center, Non-interventional, Open Label, Randomized (Depth of Focus Testing Sequences), Clinical Study
NCT06767319
A Non-Treatment Clinical Evaluation of the ELITA Single Piece Patient Interface for Docking Procedure With the ELITA
NCT06727799
Clinical Investigation of the TECNIS® Next-Generation Intraocular Lens
NCT06377514
Evaluation of Real-World Data on the Performance of the TECNIS Odyssey™ IOL
NCT05991960
User Acceptability Evaluation of Pseudophakic Patients Previously Implanted With the TECNIS Odyssey IOL
NCT06005675
A Phased, Prospective, Multi-center Study OF THE Elita System
NCT05713253
Clinical Investigation of Healon EndoCoat Ophthalmic Viscosurgical Device (OVD)
NCT05575063
Clinical Investigation of the TECNIS® Next-Generation Intraocular Lens, Model DEN00V
NCT05574959
A Clinical Study Comparing Postoperative Outcomes Between the TECNIS Intraocular Lens.
NCT05396599
A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products
NCT05394324
Vision Performance Evaluation of TECNIS EYHANCE™ With TECNIS SIMPLICITY™ Compared to TECNIS® 1-piece Intraocular Lenses
NCT05025345
Evaluation of the LipiFlow System With a New Activator
NCT04500821
Clinical Evaluation of the Next Generation Phaco System
NCT04332640
Evaluation of the Rotational Stability of the Tecnis Toric II IOL
NCT04327518
Post-market Study to Obtain Surgeon Feedback on Clinical Outcome in Eyes Implanted With TECNIS Toric II IOL
NCT04210232
Clinical Investigation of the Safety and Effectiveness of an Investigational Model of the TECNIS® Intraocular Lens
NCT03949335
Post-Approval Study of the TECNIS SYMFONY® Toric Lenses
NCT03791619
A Post-Market Evaluation of LipiFlow Treatment in Cataract Surgery Practice
NCT03708367
Clinical Investigation of the Next Generation Intraocular Lens
NCT03500198
Therapeutic Areas
What is open in the Johnson & Johnson Surgical Vision pipeline
1 recruiting of 22 indexed (5% open); 18 completed (82%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Corneal Astigmatism (2 trials), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Johnson & Johnson Surgical Vision: open-pipeline peers nationwide
Peers matched on 22 registered trials and 5% open enrollment, not the therapeutic-area sidebar.
Johnson & Johnson Surgical Vision sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 22 trials (± recruiting share)
- Alaunos Therapeutics · 22 trials · 0% recruiting
- Alexza Pharmaceuticals · 22 trials · 0% recruiting
- Calithera Biosciences · 22 trials · 0% recruiting
- Fate Therapeutics · 22 trials · 14% recruiting
Sponsors near 5% open enrollment (± trial volume)
- Theranica · 5% recruiting · 22 trials
- LEO Pharma · 5% recruiting · 65 trials
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections · 4% recruiting · 45 trials
- Galderma R&D · 4% recruiting · 158 trials
Related
What to do with this Johnson & Johnson Surgical Vision page
22 registered trials is a research-attention snapshot, not an endorsement of Johnson & Johnson Surgical Vision or any single study.
- 1 of Johnson & Johnson Surgical Vision's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Corneal Astigmatism is the condition Johnson & Johnson Surgical Vision studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Corneal Astigmatism trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Johnson & Johnson Surgical Vision pipeline card: 22 registered trials from official public datasets.Report a data error.